Sector revisions Merck & Co., Inc.

Stocks

Market Closed - NYSE Other stock markets 23:01:40 16/06/2026 +03			5-day change	1st Jan Change
115.17 ^USD	+0.23%		-3.70%	+9.41%

06-16	Merck Signs Drug Discovery, Licensing Deal With Protillion Biosciences	MT
06-16	Moderna announces executive changes ahead of potential launches	RE

Add to a list 0 selected To use this feature you must be a member Log in Sign up	4m. EPS revision	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
MERCK & CO., INC.					27
MERCK KGAA					16
HALOZYME THERAPEUTICS, INC.					10
KYOWA KIRIN CO., LTD.					11
SK BIOPHARMACEUTICALS CO., LTD.					11
YUHAN CORPORATION					18
BETTA PHARMACEUTICALS CO., LTD.					1
SUPERNUS PHARMACEUTICALS, INC.					6
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.				-	-
SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.				-	-
DBV TECHNOLOGIES					3
KISSEI PHARMACEUTICAL CO., LTD.					6
OSCOTEC INC.				-	1
FRONTIER BIOTECHNOLOGIES INC.	-	-	-	-	-
ETON PHARMACEUTICALS, INC.					3
YOUCARE PHARMACEUTICAL GROUP CO., LTD.				-	-
Average					9
Weighted average by Cap.					24